Vector VestAdvertisement Vector VestAdvertisement SPDR Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

CTIX RSS Feed
Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, BooDog, KarinCA, noretreat, TOB, starbuxsux
Search This Board:
Last Post: 1/26/2015 7:14:22 AM - Followers: 564 - Board type: Free - Posts Today: 7

Cellceutix Corporation (CTIX) 
 

 

http://cellceutix.com/
 

 
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
Email:  info@cellceutix.com
 
CIK:  0001355250
 
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.

 

Management:   http://cellceutix.com/team/
The above link is kept updated.
http://www.zoominfo.com/p/Daniel-Jorgensen/1064701588
 

 
Ongoing Human Trials:  http://clinicaltrials.gov/ct2/results?term=Cellceutix+Pharmaceuticals&Search=Search
 
Product Pipeline:  http://cellceutix.com/pipeline/
 

 
Recent News and Press Releases: 
http://finance.yahoo.com/q/h?s=CTIX+Headlines

Seeking Alpha focus articles on CTIX: http://seekingalpha.com/symbol/CTIX
 
http://cellceutix.com/category/press-release/
 
SEC Filings:  http://www.sec.gov/cgi-bin/browse-edgar?company=Cellceutix+Corp&match=&CIK=ctix&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com/

 
Share Structure:  See SEC filing link above for current share structure
 

Cellceutix IP - Patent Filings:
EPO
http://worldwide.espacenet.com/searchResults?PA=Cellceutix&DB=EPODOC&locale=en_EP&ST=advanced&compact=false
WIPO
http://www.wipo.int/patentscope/search/en/detail.jsf?docId=WO2010135170&recNum=1&docAn=US2010034838&queryString=FP:(Cellceutix)&maxRec=1
USPTO
http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=0&f=S&l=50&TERM1=Cellceutix&FIELD1=AS&co1=AND&TERM2=&FIELD2=&d=PG01 


http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,796,275.PN.&OS=PN/8,796,275&RS=PN/8,796,275
 

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
 
External Links: USPTO, USPTO Assignment, Espacenet


http://www.google.com/patents/US8338454

http://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=6&f=G&l=50&co1=AND&d=PG01&s1=Cellceutix.AS.&OS=AN/Cellceutix&RS=AN/Cellceutix

 
Investor Relations:  info@cellceutix.com

Following is a WEEKLY chart:


 
 

 
 
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
 
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
 
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTIX
Current Price
Volume:
Bid Ask Day's Range
Wiki
CTIX News: Special "Tech Boom" Profile and 4 Companies That May Take Investors for a Growth Ride 01/21/2015 07:00:00 AM
CTIX News: MMJ Equipment Manufacturer, Surna Inc. Stands Out Among Companies Involved In Growing High Tech Industries 01/07/2015 07:00:00 AM
CTIX News: Statement of Changes in Beneficial Ownership (4) 01/02/2015 10:23:30 AM
CTIX News: Current Report Filing (8-k) 12/29/2014 07:48:06 AM
CTIX News: Notice of Effectiveness (effect) 11/19/2014 06:01:25 AM
PostSubject
#88668  Sticky Note News: Cellceutix Phase 2b Clinical Trial of noretreat 01/22/15 07:05:19 AM
#88579  Sticky Note Some of the catalysts I'm waiting/hoping for in ericseb2003 01/21/15 03:10:46 PM
#87958  Sticky Note Cellceutix Reports Spleen Lesion 'Disappears' in Patient With starbuxsux 01/20/15 08:25:55 AM
#82182  Sticky Note Cellceutix’s Prurisol: A Potential Blockbuster Psoriasis Treatment TOB 12/12/14 02:57:09 PM
#82180  Sticky Note $CTIX Lead drug info, News, SEC filings, FDA KarinCA 12/12/14 02:53:03 PM
#74575  Sticky Note Cellceutix Announces Positive Top-Line Data From Phase 2b TOB 10/23/14 11:59:10 AM
#89234   Thanks JohnB for getting the news out here 58nout 01/26/15 07:21:16 AM
#89233   Ya Ba Da Ba Doo!!! up listing coming cabel 01/26/15 07:14:22 AM
#89232   Uplisting is on the way! I thought it John B 01/26/15 07:08:55 AM
#89231   Cellceutix Plans Clinical Trial in Patients With Ulcerative Proctitis John B 01/26/15 07:04:08 AM
#89230   Expect more good news regarding Cellceutix this week!!! georgejjl 01/26/15 06:41:47 AM
#89229   Good Morning, World Good Morning, CTIX! Everyone have smitter 01/26/15 06:06:52 AM
#89228   Kevetrin is the perfect candidate for BTD and FarmaZutical 01/26/15 12:20:30 AM
#89227   From an old interview: sox040713 01/25/15 11:55:30 PM
#89226   That was a righteous post winnail 01/25/15 11:44:47 PM
#89225   Home of the samford cartnails Ebuilder 01/25/15 11:20:24 PM
#89224   I updated that post with new information! LOL Drano 01/25/15 11:16:12 PM
#89223   LoL....that there is funny Ebuilder 01/25/15 11:14:49 PM
#89222   Wow, a degree from "HarWard University of U.S.A." Drano 01/25/15 11:10:00 PM
#89221   To clarify: TOB 01/25/15 11:07:02 PM
#89219   Btw, this part is actually correct since he KarinCA 01/25/15 10:51:11 PM
#89218   It looks like Menon's partner in the development Ebuilder 01/25/15 10:24:40 PM
#89215   Yes, that is part of it. An KarinCA 01/25/15 10:08:08 PM
#89214   Would you agree they have the preliminary data F1ash 01/25/15 09:56:58 PM
#89213   Is this the mistake you're referencing? http://www.thehindu.com/todays-paper/tp-national/tp-kerala Ebuilder 01/25/15 09:42:39 PM
#89212   Yes the words ideal, ovarian, pancreatic, orphan, and djs7 01/25/15 09:37:57 PM
#89211   Did the pre-clinical data for Kevetrin ever get Ebuilder 01/25/15 09:32:58 PM
#89210   Don't be defensive, this is not passive-aggressiveness, this frrol 01/25/15 09:31:56 PM
#89209   Asking for pharma-experienced posters' insights on article requests frrol 01/25/15 09:23:24 PM
#89207   There are knowns, unknowns, and unknowables. Take scottsmith 01/25/15 08:54:13 PM
#89206   I think you're right, that is the most frrol 01/25/15 08:53:37 PM
#89205   Bad example; management had B's trial results. And frrol 01/25/15 08:50:00 PM
#89204   That's what I kind of worry about, posters frrol 01/25/15 08:46:10 PM
#89203   I agree that sponsor should publish clinical data, sox040713 01/25/15 08:41:05 PM
#89202   Your recent posts border on desperation, and maybe etradeedge 01/25/15 08:11:48 PM
#89201   Staying free from bias should need to be F1ash 01/25/15 08:04:26 PM
#89200   vip999, Nobody is questioning who cares or not... Rdunn88 01/25/15 08:01:22 PM
#89199   Well we have heard some good things early frrol 01/25/15 07:57:51 PM
#89198   Not scared at all. Looking for objective support frrol 01/25/15 07:53:42 PM
#89197   I can't say really. But it seems Ebuilder 01/25/15 07:25:47 PM
#89196   You sound like a very nervous and scared etradeedge 01/25/15 07:21:52 PM
#89195   The report about the spleen lesion that disappeared BigKahuna 01/25/15 07:20:53 PM
#89193   Ebuilder is what you're saying is that we frrol 01/25/15 07:04:09 PM
#89192   I think we over-estimate how much management knows. frrol 01/25/15 06:57:10 PM
#89191   I follow my cancer, multiple myeloma, pretty close. Ebuilder 01/25/15 06:57:03 PM
#89190   I read everything I can about my CTIX frrol 01/25/15 06:46:59 PM
#89189   My hope is the presentation will be ASCO farrell90 01/25/15 06:24:34 PM
#89188   You seemed to have your studies and PRs farrell90 01/25/15 06:19:03 PM
#89187   " be ready for more volatility in coming eventhelosers 01/25/15 06:07:26 PM
#89186   Then I guess we will be back under BobbyKIrk 01/25/15 06:06:20 PM
#89185   Hint, hint, indeed. ;-) Go CTIX! TheDane 01/25/15 05:55:23 PM
#89183   Karin your post is an excellent summary of farrell90 01/25/15 05:45:58 PM
#89182   Agreed. If Kevetrin results are not as positive thefamilyman 01/25/15 05:40:48 PM
#89180   When a Big Pharma puts their stamp of eventhelosers 01/25/15 05:29:32 PM
#89179   Karin, if we get that partner, would you eventhelosers 01/25/15 05:26:07 PM
#89178   If the results are not positive and CTIX Chemdeps 01/25/15 04:47:15 PM
PostSubject